STEMLINE THERAPEUTICS INC SEC Filings

Filed On	Filing
12 Feb 2021	SC 13G/A
22 Jun 2020	15-12B
16 Jun 2020	EFFECT
16 Jun 2020	EFFECT
16 Jun 2020	EFFECT
10 Jun 2020	S-8 POS
10 Jun 2020	S-8 POS
10 Jun 2020	S-8 POS
10 Jun 2020	S-8 POS
10 Jun 2020	S-8 POS
10 Jun 2020	S-8 POS
10 Jun 2020	POS AM
10 Jun 2020	POS AM
10 Jun 2020	POS AM
10 Jun 2020	Form 4: Gionco David, Chief Accounting Officer Received 45,000 shares as a grant or award · Disposed of 327,878 shares (Tender Offer) · Disposed of 45,102 Employee Stock Option (right to buy) (Disposition to Issuer)
10 Jun 2020	Form 4: Sard Mark, Director Disposed of 51,468 shares (Tender Offer)
10 Jun 2020	Form 4: Hume Daniel, Director Disposed of 35,468 shares (Tender Offer)
10 Jun 2020	Form 4: Bergstein Ivan, Director Received 220,000 shares as a grant or award · Disposed of 3,024,336 shares (Tender Offer) · Disposed of 627,756 Employee Stock Option (right to buy) (Disposition to Issuer)
10 Jun 2020	Form 4: Bentsur Ron, Director Disposed of 66,346 shares (Tender Offer) · Disposed of 85,104 Stock Option (right to buy) (Disposition to Issuer)
10 Jun 2020	Form 4: Hoberman Kenneth, Chief Operating Officer Received 600,000 shares as a grant or award · Disposed of 1,374,352 shares (Tender Offer) · Disposed of 69,058 Employee Stock Option (right to buy) (Disposition to Issuer)

Comments